Page last updated: 2024-08-22

hyaluronoglucosaminidase and n(6)-cyclopentyladenosine

hyaluronoglucosaminidase has been researched along with n(6)-cyclopentyladenosine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bressi, JC; Buckner, FS; Choe, J; Gelb, MH; Hol, WG; Hough, MT; Van Voorhis, WC; Verlinde, CL1
Cappellacci, L; Franchetti, P; Graser, G; Grifantini, M; Jayaram, HN; Lavecchia, A; Petrelli, R; Saiko, P; Szekeres, T; Vita, P1

Other Studies

2 other study(ies) available for hyaluronoglucosaminidase and n(6)-cyclopentyladenosine

ArticleYear
Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Journal of medicinal chemistry, 2000, Nov-02, Volume: 43, Issue:22

    Topics: Adenosine; Animals; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenases; Glycerolphosphate Dehydrogenase; Models, Molecular; Molecular Conformation; Phosphoglycerate Kinase; Protein Binding; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi

2000
Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Ribonucleotide Reductases; Ribose; Structure-Activity Relationship

2008